公司資料

Assertio 股價、新聞與催化劑

股票代碼:: ASRT
交易所:: NASDAQ
產業:: Biopharma
所在地:: United States

股票表現

23.50 USD (+0.13%)

收盤價

最後更新: 2026年6月15日

152M USD

市值

股價為何變動

Current closing-price context is not available for ASRT.

公司概覽

業務概覽

Assertio is a specialty pharmaceutical company with a portfolio of neurology, pain, and related products. The story is largely about managing a concentrated commercial base while expanding selectively.

所在地與產業分類

Headquartered in the United States and listed on NASDAQ, Assertio sits in specialty biopharma.

商業模式特徵

The business depends on product revenue, portfolio management, and the ability to stabilize and grow its commercial assets.

生技產業定位

Assertio is a specialty-pharma turnaround name with a story shaped by product mix and execution.

未來催化劑

Assertio’s catalysts are its branded pain and neurology portfolio, including Sympazan and Indocin, plus any capital-allocation or portfolio-optimization update. The market will care more about cash generation and simplification than about big pipeline headlines.